Once reserved for hospital environments or highly controlled laboratories, biosecurity has become a shared concern for many of us, especially considering that we spend most of our time indoors. With new outbreaks of the Covid-19 Delta variant detected in various states—driving a 9% increase in the epidemiological curve—families continue to seek the protection and resources needed to safeguard their spaces, ensuring sanitary safety against constant exposure to infections, viruses, and bacteria that pose potential health risks.
In response to these new circumstances, PPG Comex allocates a significant portion of its annual revenue to research and development, bringing a wider range of high-performance, efficient solutions to the market. In line with the health and wellness macro-trend, the company reformulated Vinimex Total Antibacterial to incorporate antiviral properties. Third-party laboratory testing has verified these antiviral and antibacterial attributes, proving up to a 99.9% reduction in the replication of the SARS-CoV-2 virus (which causes Covid-19), the H1N1 influenza virus, and the four primary bacteria that cause gastrointestinal illnesses (Escherichia coli, Salmonella typhimurium) and respiratory infections (Pseudomonas aeruginosa, Staphylococcus aureus).
